Figure 6
From: Enhancing hepatoprotective action: oxyberberine amorphous solid dispersion system targeting TLR4
Effects of OBB-ASDs on oxidative and inflammatory stress. (A) IL-1β, (B) IL-6, (C) TNF-α, (D) MCP-1, (E) CAT, (F) GSH, (G) SOD, (H) MDA. Results are means ± SD (n = 6). #P < 0.05, ##P < 0.01 vs. Normal control group; *P < 0.05, **P < 0.01 vs. LPS/D-GalN group; &P < 0.05, &&P < 0.01 vs. OBB-SUS group.
